Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 Secretion during latent infection through changes in the cellular microRNA hsa-miR-92a.

Poole E, Avdic S, Hodkinson J, Jackson S, Wills M, Slobedman B, Sinclair J.

J Virol. 2014 Dec;88(24):13947-55. doi: 10.1128/JVI.02424-14. Epub 2014 Sep 24.

2.

Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.

Jenkins C, Garcia W, Godwin MJ, Spencer JV, Stern JL, Abendroth A, Slobedman B.

J Virol. 2008 Apr;82(7):3736-50. doi: 10.1128/JVI.02173-07. Epub 2008 Jan 23.

3.

Sleepless latency of human cytomegalovirus.

Poole E, Sinclair J.

Med Microbiol Immunol. 2015 Jun;204(3):421-9. doi: 10.1007/s00430-015-0401-6. Epub 2015 Mar 14. Review.

4.

Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.

Fu M, Gao Y, Zhou Q, Zhang Q, Peng Y, Tian K, Wang J, Zheng X.

Gene. 2014 Feb 25;536(2):272-8. doi: 10.1016/j.gene.2013.12.012. Epub 2013 Dec 18.

PMID:
24361963
5.

Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency.

O'Connor CM, Vanicek J, Murphy EA.

J Virol. 2014 May;88(10):5524-32. doi: 10.1128/JVI.00481-14. Epub 2014 Mar 5.

6.

Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells.

Mason GM, Jackson S, Okecha G, Poole E, Sissons JG, Sinclair J, Wills MR.

PLoS Pathog. 2013;9(10):e1003635. doi: 10.1371/journal.ppat.1003635. Epub 2013 Oct 10.

7.

Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection.

Jenkins C, Garcia W, Abendroth A, Slobedman B.

Virology. 2008 Jan 20;370(2):285-94. Epub 2007 Oct 17.

8.

The Expression of Human Cytomegalovirus MicroRNA MiR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6.

Lau B, Poole E, Krishna B, Sellart I, Wills MR, Murphy E, Sinclair J.

Sci Rep. 2016 Aug 5;6:31205. doi: 10.1038/srep31205.

9.

Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.

Young VP, Mariano MC, Tu CC, Allaire KM, Avdic S, Slobedman B, Spencer JV.

J Infect Dis. 2017 Mar 15;215(6):874-882. doi: 10.1093/infdis/jix043.

10.

The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency.

Cheung AK, Gottlieb DJ, Plachter B, Pepperl-Klindworth S, Avdic S, Cunningham AL, Abendroth A, Slobedman B.

Blood. 2009 Nov 5;114(19):4128-37. doi: 10.1182/blood-2008-12-197111. Epub 2009 Aug 25.

11.

Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.

Humby MS, O'Connor CM.

J Virol. 2015 Dec 30;90(6):2959-70. doi: 10.1128/JVI.02507-15.

12.

Human Cytomegalovirus-Encoded Human Interleukin-10 (IL-10) Homolog Amplifies Its Immunomodulatory Potential by Upregulating Human IL-10 in Monocytes.

Avdic S, McSharry BP, Steain M, Poole E, Sinclair J, Abendroth A, Slobedman B.

J Virol. 2016 Mar 28;90(8):3819-3827. doi: 10.1128/JVI.03066-15. Print 2016 Apr.

13.

Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.

Tu CC, Arnolds KL, O'Connor CM, Spencer JV.

J Virol. 2018 Feb 12;92(5). pii: e01981-17. doi: 10.1128/JVI.01981-17. Print 2018 Mar 1.

14.

Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34⁺ progenitors.

Poole E, McGregor Dallas SR, Colston J, Joseph RS, Sinclair J.

J Gen Virol. 2011 Jul;92(Pt 7):1539-49. doi: 10.1099/vir.0.031377-0. Epub 2011 Apr 6.

PMID:
21471310
15.

Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Kim JH, Collins-McMillen D, Buehler JC, Goodrum FD, Yurochko AD.

J Virol. 2017 Feb 14;91(5). pii: e01206-16. doi: 10.1128/JVI.01206-16. Print 2017 Mar 1.

16.

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D.

J Virol. 2014 Aug;88(16):9391-405. doi: 10.1128/JVI.00934-14. Epub 2014 Jun 11.

17.

Aspects of human cytomegalovirus latency and reactivation.

Reeves M, Sinclair J.

Curr Top Microbiol Immunol. 2008;325:297-313. Review.

PMID:
18637513
18.

Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function.

Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH.

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14538-43. doi: 10.1073/pnas.1204836109. Epub 2012 Jul 23.

19.

Human cytomegalovirus manipulation of latently infected cells.

Sinclair JH, Reeves MB.

Viruses. 2013 Nov 21;5(11):2803-24. doi: 10.3390/v5112803. Review.

20.

Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.

Krishna BA, Poole EL, Jackson SE, Smit MJ, Wills MR, Sinclair JH.

MBio. 2017 Dec 5;8(6). pii: e01754-17. doi: 10.1128/mBio.01754-17.

Supplemental Content

Support Center